Leading Indian MedTech Company Shalya – Xcellance Medical Technologies Pvt Ltd Receives Prestigious Recognition at MedTech Policy Mahotsav Conclave 2023

New Delhi (India), June 23: In the contemporary world where numbers often narrate a tale of triumph, Xcellance Medical Technologies Pvt Ltd, globally known by its brand name – Shalya, stands tall as a paragon of innovation. With a colossal manufacturing facility spread over an impressive area of 5000 square meters, a workforce of over 300 dedicated employees, a strong Research & Development team comprising more than 25 engineers, and a staggering 15 global patents to its name, Shalya has carved a niche for itself in the competitive sphere of medical technology. Shalya’s relentless pursuit of excellence has not gone unnoticed, and the company’s impactful contribution to the field of medical devices was recently celebrated at the MedTech Policy Mahotsav Conclave 2023.

Taking place on June 17 in Delhi, this prestigious event was organised by Medgate Today Magazine, a respected voice in the realm of medical technology and healthcare. Shalya was bestowed with “The Good Samaritan Award,” honouring the company’s dedication and persistent efforts to serve humanity and the nation through its revolutionary innovations. Shalya’s unwavering commitment to propel the boundaries of innovation in the medical device industry has made it one of India’s leading players in this field, and this recognition amplifies the positive impact of its work.

The MedTech Policy Mahotsav Conclave 2023 also saw the participation of Mr. Pradeep Narkhede, Founder and Managing Director of Shalya. Mr. Narkhede was invited as a panelist during the event, where he addressed the topic, “Navigating challenges and opportunities in public procurement of medical devices under the Make in India vision”. This platform provided Shalya with an opportunity to share insights about the influence of the Make In India initiative and discuss the hurdles that Indian MedTech manufacturers continue to face when it comes to public procurement.

Shalya prides itself on its innovative ethos, built on the dedication of its exceptional team, which constantly strives to address the evolving needs of healthcare professionals by leveraging emerging technology. The company has proved its mettle time and again by offering comprehensive equipment solutions for electrosurgery, laparoscopy, operating room lights, pendant, tables, and operating room (OR) integration system. Shalya’s product line, which includes customizable OR lights and pendants, is complemented by an efficient turnaround time for delivery, further distinguishing the brand in the industry.

The company’s ground-breaking hand-activated laparoscopic bipolar cutting device is used globally, further testament to its pioneering spirit and a clear demonstration of its commitment to serve the healthcare industry. Shalya’s commendable achievement at the MedTech Policy Mahotsav Conclave 2023 underlines its unwavering dedication towards touching lives by innovation.

Founded by Mr. Pradeep Narkhede over two decades ago, Shalya was born from a desire to bridge the gap between advanced medical technologies and affordable healthcare solutions in India. Over time, the company has responded to the changing needs of healthcare, evolving into an award-winning enterprise known for its cutting-edge electrosurgical technology, including advanced electrosurgical units for cardiac, neurosurgical, and advanced laparoscopic applications, and saline plasma resection. Today, Shalya – Xcellance Medical Technologies Pvt Ltd stands as India’s first medical equipment manufacturing company to acquire CE certification in electrosurgery and meet other global regulatory requirements thus cementing its reputation for surgical precision and safety, serving more than 70 countries globally. 

For more information visit:  https://www.shalya.in/

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.